Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Theregen Corp.
DescriptionEpicardial patch
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationCoronary artery disease (CAD)
Indication DetailsTreat diffuse small vessel coronary artery disease (CAD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today